New radioactive tracer tested for cancer imaging in tiny early trial
NCT ID NCT06463782
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-phase trial tested a single injection of a radioactive imaging agent called 68Ga-LNC1007 in 8 adults (healthy volunteers and solid tumor patients). The goal was to check its safety, how it moves through the body, and how well it shows up on scans. The study is already completed, but it is too small and early to draw any conclusions about diagnosing or treating cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
68Ga-LNC1007 injection (a radioactive imaging agent)
What this could lead to
If successful, this could lead to a new imaging method to help detect or monitor solid tumors more precisely.
What could go wrong
This is a very early, small trial (8 people) focused only on safety and imaging properties, not on treating cancer. It may not lead to any diagnostic or therapeutic benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Imaging Research Centre (CIRC) ；National University of Singapore.
Singapore, Singapore